|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-3-18
|
|
pubmed:abstractText |
The new antitubercular drug candidate 2-[2-S-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (BTZ043) targets the DprE1 (Rv3790) subunit of the enzyme decaprenylphosphoryl-beta-d-ribose 2'-epimerase. To monitor the potential development of benzothiazinone (BTZ) resistance, a total of 240 sensitive and multidrug-resistant Mycobacterium tuberculosis clinical isolates from four European hospitals were surveyed for the presence of mutations in the dprE1 gene and for BTZ susceptibility. All 240 strains were susceptible, thus establishing the baseline prior to the introduction of BTZ043 in clinical trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1098-6596
|
|
pubmed:author |
pubmed-author:BrerraRobertoR,
pubmed-author:ColeStewart TST,
pubmed-author:De MoriPatriziaP,
pubmed-author:DegiacomiGiuliaG,
pubmed-author:HeymBeateB,
pubmed-author:MakarovVadimV,
pubmed-author:MirrioneMaurizioM,
pubmed-author:PaganiLauraL,
pubmed-author:PascaMaria RosaliaMR,
pubmed-author:PucilloLeopoldoL,
pubmed-author:RibeiroAna Luisa de Jesus LopesAL,
pubmed-author:RiccardiGiovannaG,
pubmed-author:TroupiotiPanajotaP,
pubmed-author:ZaraFrancescaF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1616-8
|
|
pubmed:dateRevised |
2010-10-4
|
|
pubmed:meshHeading |
pubmed-meshheading:20086151-Antitubercular Agents,
pubmed-meshheading:20086151-Base Sequence,
pubmed-meshheading:20086151-DNA, Bacterial,
pubmed-meshheading:20086151-DNA Primers,
pubmed-meshheading:20086151-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:20086151-Europe,
pubmed-meshheading:20086151-Genes, Bacterial,
pubmed-meshheading:20086151-Humans,
pubmed-meshheading:20086151-Microbial Sensitivity Tests,
pubmed-meshheading:20086151-Mutation,
pubmed-meshheading:20086151-Mycobacterium tuberculosis,
pubmed-meshheading:20086151-Racemases and Epimerases,
pubmed-meshheading:20086151-Spiro Compounds,
pubmed-meshheading:20086151-Thiazines,
pubmed-meshheading:20086151-Tuberculosis, Multidrug-Resistant
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones.
|
|
pubmed:affiliation |
University of Pavia, Department of Genetics and Microbiology, Via Ferrata 1, 27100 Pavia, Italy. m.pasca@ipvgen.unipv.it
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|
